Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein
Beta LifeScience
SKU/CAT #: BLK-01031P-100UG

Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein
Beta LifeScience
SKU/CAT #: BLK-01031P-100UG
Collections: Fc receptors, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Human HBV(HLA-A*02:01) Protein is expressed from HEK293 with His tag and Avi tag at the C-TerminusIt contains Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M) and FLLTRILTI peptide. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | A0A140T913(HLA-A*02:01)&P61769(B2M)&FLLTRILTI peptide |
Target Symbol | HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and FLLTRILTI peptide |
Mol. Weight | The protein has a predicted MW of 50.5 kDa. Due to glycosylation, the protein migrates to 52-62 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). |